Journal of neurologyHumansLeuprolideMaleMiddle AgedFemale
Therapeutic impact of leuprorelin acetate on spinal and bulbar muscular atrophy: pre- and post-marketing observational study.
Atsushi Hashizume, Ryoichi Hanazawa, Shinichiro Yamada, Daisuke Ito, Yoshiyuki Kishimoto, Shota Komori, Takahiro Kawase, Madoka Iida, Ayano Kondo, Yu Mori, Kazuki Obara, Mitsuya Morita, Tomotaka Yamamoto, Hiroyuki Sato, Akihiro Hirakawa
Published: 202510.1007/s00415-025-13509-y
Abstract
Although leuprorelin acetate, a luteinizing hormone-releasing hormone agonist, has been approved based on short-term clinical trials conducted in Japan, its long-term efficacy on physical function remains unclear. We aimed to evaluate the long-term t…
Preview only. Read the full abstract at the source